RENE GONZALEZ to Neoplasms
This is a "connection" page, showing publications RENE GONZALEZ has written about Neoplasms.
Connection Strength
0.119
-
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers. Cancer. 2024 May 15; 130(10):1784-1796.
Score: 0.079
-
Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignancies. Clin Cancer Res. 2011 Dec 15; 17(24):7765-75.
Score: 0.034
-
PI-88: a novel inhibitor of angiogenesis. Expert Opin Investig Drugs. 2008 Nov; 17(11):1769-76.
Score: 0.007